摘要
目的:了解基础状态动物模型肾局部RAS的水平,观察其在用转换酶抑制剂(ACEI)和血管紧张素受体拮抗剂(AT1RA)干预治疗后的变化,探讨、比较这两种药物对肾保护作用的分子生物学机制。方法:用反转录聚合酶链反应(RT-PCR), 分别对自发性高血压大鼠(SHR)肾皮质内ACE和AT1 受体m RNA表达进行测定,观察用ACEI或AT1RA干预治疗后的变化。结果:(1)与WKY比,基础状态下SHR肾皮质内ACE和AT1受体m RNA表达均显著升高(两组P< 0.05);(2)与对照组相比,用ACEI后SHR 肾皮质内ACEm RNA 被抑制(P< 0.05),但AT1 受体m RNA无变化;(3)与对照组相比,用AT1RA后,SHR肾皮质内ACE和AT1 受体m RNA均被抑制(两组P< 0.05)。结论:ACEI和AT1RA 都对SHR局部RAS有作用,但作用机理和途径可能不同,AT1 受体可能存在多方面调节机制。ACEI似乎仅作用于ACE,对AT1 受体可能没有直接作用;AT1RA在作用于AT1 受体的同时。
Objective: To investigated the local RAS level in kidney of rats and its changes after the interventions of ACEI and AT 1RA in order to explore the molecular mechanism of the protective effects on kindey of these two drugs. Methods:Used RT-PCR to detect the ACE and AT 1 mRNA expressions in renal cortex of spontaneous hypertensive rats(SHR) and Wistar Kyoto rats(WKY) before and after applied ACEI or AT 1RA treatment. Results: (1)Compared with WKY, both ACE and AT 1 mRNA expressions in SHR were significantly higher( P <0.05);(2)ACE mRNA expression in SHR was inhibited after ACEI treatment( P <0.05), while these was no changes in AT 1 mRNA expression;(3)ACE and AT 1 mRNA expressions in SHR were both inhibited after AT 1RA treatment. Conclusion: Both ACEI and AT 1RA had local effects on RAS in SHR, but their mechanisms might be differenct. It was suggested that AT 1 receptor had multipule regulations pathways. ACEIs seems solely affect on ACE, while no direct effect on AT 1 receptor was found. However, AT 1RA might have effect on ACE through regulation of AT 1 receptor.
出处
《高血压杂志》
CSCD
1999年第4期368-370,共3页
Chinese Journal of Hypertension
基金
上海市教委资助!项目(95B12)